MedPath

Conchoice

Brand Name: Conchoice

Generic Name: Levonorgestrel + Ethinylestradiol Conchoice

Active
Registration Number

DRP-12686

Dosage Form

Tablet

Issuance Date

May 31, 2024

Expiry Date

April 27, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength150 mcg/30 mcg
PackagingAlu/PVC Clear Blister Pack x 21's (Box of 21's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Hormonal Contraceptive
A
Application
Initial (Reconstruction)
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

LevonorgestrelActive
Monograph: Levonorgestrel
Ethinylestradiol ConchoiceActive
Monograph: ethinylestradiol conchoice

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.